SCO stands for coordination of efforts in fight against terrorist threatWorld October 29, 0:42
Russia does not plan to ratify Paris Agreement on climate earlier than 2020 — ministerRussian Politics & Diplomacy October 28, 21:48
Russian Foreign Ministry: Pictures of attacked school in Idlib are 'computer graphics'World October 28, 21:21
Kissinger becomes Russian Academy of Sciences memberWorld October 28, 21:12
Kremlin gives no comment on reports that Russian, US jets flew dangerously close in SyriaRussian Politics & Diplomacy October 28, 20:13
Two of four Soyuz crews to fly to ISS in 2017 will be smaller than usualScience & Space October 28, 20:05
Foreign Ministry: Two mortar shells fired on Russian embassy in SyriaRussian Politics & Diplomacy October 28, 19:52
Kremlin: Russia may use all available means against terrorists in AleppoRussian Politics & Diplomacy October 28, 19:26
Russian Foreign Ministry refutes reports about alleged deportation of Russians from SerbiaRussian Politics & Diplomacy October 28, 19:07
MOSCOW, December 22. /TASS/. Some 16 major Russian pharmaceutical companies have stopped the production of “the cheapest and the most essential drugs,” including antibiotics and fluids, the chairman of the State Duma health committee Sergey Kalashnikov said on Monday.
“This comes due to a sharp increase in the dollar price for the substances which are bought abroad,” Kalashnikov said, adding that the prime cost of medicines is now some three or four times higher than the actual price amid weakened ruble.
The members of the State Duma health committee as well as representatives of the Russian Health Ministry, the Ministry of Industry and Trade, the Federal Anti-Monopoly Service and the Federal Tariff Service are due to focus on the situation at an urgent meeting later on Monday.
“The main goal is to develop a concept for work in emergency conditions to ensure uninterrupted access to medicines,” Kalashnikov said, explaining that the idea is to adjust prices for foreign-made life-saving drugs and resume the production of pharmaceutical substances in Russia.
The lawmaker in particular proposes that Russia should follow the example of India and Brazil and introduce a mechanism of mandatory licensing when “it is allowed to manufacture medicines, generics if a patent has not expired.” This concerns the “most expensive medicines” which are used to treat such diseases as cancer and AIDS, he said.